Skip to main
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is a leading medical technology company with a disruptive breast implant technology, a strong global presence, and multiple growth drivers. Its U.S. business is the primary growth driver, with consistent growth and increasing account penetration being driven by strong demand for the unique Motiva breast implant brand. Additionally, the company has a diverse pipeline of innovative products and procedures, strong financial performance, and a bullish outlook for future growth. These factors, along with the company's successful marketing of newer, minimally invasive surgery techniques, product iterations and pipeline developments make it a compelling investment opportunity.

Bears say

Establishment Labs Hldgs is experiencing strong revenue growth and positive adjusted EBITDA, but the growth is largely coming from one product - US Motiva. Their international revenue is growing at a slower rate, and there are uncertainties around the approval of their reconstruction label expansion and the success of their minimally invasive platform. Furthermore, their plans for a full US commercial launch of their Preservé product may face challenges in terms of training enough surgeons and converting new patients.

ESTA has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Strong Buy based on their latest research and market trends.

According to 8 analysts, ESTA has a Strong Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.